Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion. Cephalon Inc, Federal Trade Commission, Thomas, Katie, Antitrust Laws and Competition Issues, Drugs (Pharmaceuticals), Generic Brands and Products